Cited by 51Bioinformatics and Genomic NetworksCancer Genomics and DiagnosticsGene expression and cancer classification

TMO-Net: an explainable pretrained multi-omics model for multi-task learning in oncology

Open access
Wang, Feng-ao, Zhuang, Zhenfeng, Gao, Feng, He, Ruikun, Zhang, Shaoting, Wang, Liansheng, Liu, Junwei, Li, Yixue·2024·Genome Biology

Abstract

Cancer is a complex disease composing systemic alterations in multiple scales. In this study, we develop the Tumor Multi-Omics pre-trained Network (TMO-Net) that integrates multi-omics pan-cancer datasets for model pre-training, facilitating cross-omics interactions and enabling joint representation learning and incomplete omics inference. This model enhances multi-omics sample representation and empowers various downstream oncology tasks with incomplete multi-omics datasets. By employing interpretable learning, we characterize the contributions of distinct omics features to clinical outcomes. The TMO-Net model serves as a versatile framework for cross-modal multi-omics learning in oncology, paving the way for tumor omics-specific foundation models.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13059-024-03293-9

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The development of incomplete modal learning enables more flexible and efficient representation learning in multimodal datasets.

    “Additionally, the development of incomplete modal learning enables more flexible and efficient representation learning in multimodal datasets [54,55].”
  • The authors developed the TMO-Net model for incomplete multi-omics data learning of cancer data and adapted it into multiple downstream tasks.

    “We also developed the TMO-Net model for incomplete multi-omics data learning of cancer data and adapted it into multiple downstream tasks [55].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 62

  1. [1]Martinez-Jimenez F Muinos F Sentis I Deu-Pons J Reyes-Salazar I Arnedo-Pac C Mularoni L Pich O Bonet J Kranas H A compendium of mutational cancer driver genes Nat Rev Cancer 2020 20 555 572 10.1038/s41568-020-0290-x 32778778 · DOI
  2. [2]Boehm KM Khosravi P Vanguri R Gao J Shah SP Harnessing multimodal data integration to advance precision oncology Nat Rev Cancer 2022 22 114 126 10.1038/s41568-021-00408-3 34663944 PMC8810682 · DOI · Paper page
  3. [3]Nguyen ND Huang J Wang D A deep manifold-regularized learning model for improving phenotype prediction from multi-modal data Nat Comput Sci 2022 2 38 46 10.1038/s43588-021-00185-x 35480297 PMC9038085 · DOI
  4. [4]Liu J Lichtenberg T Hoadley KA Poisson LM Lazar AJ Cherniack AD Kovatich AJ Benz CC Levine DA Lee AV An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics Cell 2018 173 400 416 e411 10.1016/j.cell.2018.02.052 29625055 PMC6066282 · DOI · Paper page
  5. [5]Zhang J Bajari R Andric D Gerthoffert F Lepsa A Nahal-Bose H Stein LD Ferretti V The international cancer genome consortium data portal Nat Biotechnol 2019 37 367 369 10.1038/s41587-019-0055-9 30877282 · DOI
  6. [6]Tran KA Kondrashova O Bradley A Williams ED Pearson JV Waddell N Deep learning in cancer diagnosis, prognosis and treatment selection Genome Med 2021 13 152 10.1186/s13073-021-00968-x 34579788 PMC8477474 · DOI · Paper page
  7. [7]Lipkova J Chen RJ Chen B Lu MY Barbieri M Shao D Vaidya AJ Chen C Zhuang L Williamson DFK Artificial intelligence for multimodal data integration in oncology Cancer Cell 2022 40 1095 1110 10.1016/j.ccell.2022.09.012 36220072 PMC10655164 · DOI · Paper page
  8. [8]Withnell E Zhang X Sun K Guo Y XOmiVAE: an interpretable deep learning model for cancer classification using high-dimensional omics data Brief Bioinform 2021 22 bbab315 10.1093/bib/bbab315 34402865 PMC8575033 · DOI · Paper page
  9. [9]Argelaguet R Arnol D Bredikhin D Deloro Y Velten B Marioni JC Stegle O MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data Genome Biol 2020 21 111 10.1186/s13059-020-02015-1 32393329 PMC7212577 · DOI · Paper page
  10. [10]Wang T Shao W Huang Z Tang H Zhang J Ding Z Huang K MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification Nat Commun 2021 12 3445 10.1038/s41467-021-23774-w 34103512 PMC8187432 · DOI · Paper page
  11. [11]Zhang X Xing Y Sun K Guo Y OmiEmbed: a unified multi-task deep learning framework for multi-omics data Cancers (Basel). 2021 13 3047 10.3390/cancers13123047 34207255 PMC8235477 · DOI
  12. [12]Feldner-Busztin D Firbas Nisantzis P Edmunds SJ Boza G Racimo F Gopalakrishnan S Limborg MT Lahti L de Polavieja GG Dealing with dimensionality: the application of machine learning to multi-omics data Bioinformatics 2023 39 btad021 10.1093/bioinformatics/btad021 36637211 PMC9907220 · DOI
  13. [13]Alatkar SA Wang D CMOT: Cross-Modality Optimal Transport for multimodal inference Genome Biol 2023 24 163 10.1186/s13059-023-02989-8 37434182 PMC10334579 · DOI · Paper page
  14. [14]Wu KE Yost KE Chang HY Zou J BABEL enables cross-modality translation between multiomic profiles at single-cell resolution Proc Natl Acad Sci U S A 2021 118 e2023070118 10.1073/pnas.2023070118 33827925 PMC8054007 · DOI
  15. [16]Chandrashekar PB Alatkar S Wang J Hoffman GE He C Jin T Khullar S Bendl J Fullard JF Roussos P Wang D DeepGAMI: deep biologically guided auxiliary learning for multimodal integration and imputation to improve genotype-phenotype prediction Genome Med 2023 15 88 10.1186/s13073-023-01248-6 37904203 PMC10617196 · DOI · Paper page
  16. [17]Cohen Kalafut N Huang X Wang D Joint variational autoencoders for multimodal imputation and embedding Nat Mach Intell 2023 5 631 42 10.1038/s42256-023-00663-z PMC11340721 39175596 · DOI
  17. [21]Huang Z Bianchi F Yuksekgonul M Montine TJ Zou J A visual-language foundation model for pathology image analysis using medical Twitter Nat Med 2023 29 2307 2316 10.1038/s41591-023-02504-3 37592105 · DOI · Paper page
  18. [23]Tu X Cao Z-J Mostafavi S Gao G Cross-linked unified embedding for cross-modality representation learning Adv Neural Inf Process Syst 2022 35 15942 15955
  19. [24]Kutuzova S, Krause O, McCloskey D, Nielsen M, Igel C: Multimodal variational autoencoders for semi-supervised learning: In defense of product-of-experts. arXiv preprint arXiv:210107240 2021.
  20. [25]Rousseeuw PJ Silhouettes: A graphical aid to the interpretation and validation of cluster analysis J Comput Appl Math 1999 20 53 65 10.1016/0377-0427(87)90125-7 · DOI · Paper page
  21. [27]Chen T Guestrin C Xgboost: A scalable tree boosting system Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining 2016 785 794
  22. [28]Sundararajan M, Taly A, Yan Q. Axiomatic attribution for deep networks. In International conference on machine learning. Sydney: PMLR; 2017. p. 3319–3328.
  23. [29]Tang X Zhang J He Y Zhang X Lin Z Partarrieu S Hanna EB Ren Z Shen H Yang Y Explainable multi-task learning for multi-modality biological data analysis Nat Commun 2023 14 2546 10.1038/s41467-023-37477-x 37137905 PMC10156823 · DOI
  24. [30]Curtis C Shah SP Chin SF Turashvili G Rueda OM Dunning MJ Speed D Lynch AG Samarajiwa S Yuan Y The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature 2012 486 346 352 10.1038/nature10983 22522925 PMC3440846 · DOI · Paper page
  25. [31]Lupat R Perera R Loi S Li J Moanna: multi-omics autoencoder-based neural network algorithm for predicting breast cancer subtypes IEEE Access 2023 11 10912 10924 10.1109/ACCESS.2023.3240515 · DOI
  26. [33]Li Q Yu Y Kossinna P Lun T Liao W Zhang Q XA4C: eXplainable representation learning via Autoencoders revealing Critical genes PLoS Comput Biol 2023 19 e1011476 10.1371/journal.pcbi.1011476 37782668 PMC10569512 · DOI
  27. [34]Karlsson E Delle U Danielsson A Olsson B Abel F Karlsson P Helou K Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer BMC Cancer 2008 8 254 10.1186/1471-2407-8-254 18778486 PMC2559847 · DOI
  28. [35]Ahn H-M Ryu J Song JM Lee Y Kim H-J Ko D Choi I Kim SJ Lee JW Kim S Anti-cancer activity of novel TM4SF5-targeting antibodies through TM4SF5 neutralization and immune cell-mediated cytotoxicity Theranostics 2017 7 594 10.7150/thno.15629 28255353 PMC5327636 · DOI
  29. [36]Finlin BS Gau C-L Murphy GA Shao H Kimel T Seitz RS Chiu Y-F Botstein D Brown PO Der CJ RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer J Biol Chem 2001 276 42259 42267 10.1074/jbc.M105888200 11533059 · DOI
  30. [37]Heylen E Verstraete P Van Aerschot L Geeraerts SL Venken T Timcheva K Nittner D Verbeeck J Royaert J Gijbels M Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer Br J Cancer 2023 128 1862 1878 10.1038/s41416-023-02216-y 36932191 PMC10147615 · DOI
  31. [38]Albaradei S Thafar M Alsaedi A Van Neste C Gojobori T Essack M Gao X Machine learning and deep learning methods that use omics data for metastasis prediction Comput Struct Biotechnol J 2021 19 5008 5018 10.1016/j.csbj.2021.09.001 34589181 PMC8450182 · DOI
  32. [39]Albaradei S Napolitano F Thafar MA Gojobori T Essack M Gao X MetaCancer: a deep learning-based pan-cancer metastasis prediction model developed using multi-omics data Comput Struct Biotechnol J 2021 19 4404 4411 10.1016/j.csbj.2021.08.006 34429856 PMC8368987 · DOI · Paper page
  33. [40]Ye B Fan D Xiong W Li M Yuan J Jiang Q Zhao Y Lin J Liu J Lv Y Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis Nat Commun 2021 12 4457 10.1038/s41467-021-24813-2 34294701 PMC8298514 · DOI
  34. [41]Fan H Zhang M Liu W Hypermethylated KCNQ1 acts as a tumor suppressor in hepatocellular carcinoma Biochem Biophys Res Commun 2018 503 3100 3107 10.1016/j.bbrc.2018.08.099 30144972 · DOI
  35. [42]Yang W Soares J Greninger P Edelman EJ Lightfoot H Forbes S Bindal N Beare D Smith JA Thompson IR Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells Nucleic Acids Res 2012 41 D955 D961 10.1093/nar/gks1111 23180760 PMC3531057 · DOI · Paper page
  36. [44]Sharifi-Noghabi H Zolotareva O Collins CC Ester M MOLI: multi-omics late integration with deep neural networks for drug response prediction Bioinformatics 2019 35 i501 i509 10.1093/bioinformatics/btz318 31510700 PMC6612815 · DOI · Paper page
  37. [45]Gillespie M Jassal B Stephan R Milacic M Rothfels K Senff-Ribeiro A Griss J Sevilla C Matthews L Gong C The reactome pathway knowledgebase 2022 Nucleic Acids Res 2022 50 D687 D692 10.1093/nar/gkab1028 34788843 PMC8689983 · DOI
  38. [47]Kim S Kim K Choe J Lee I Kang J Improved survival analysis by learning shared genomic information from pan-cancer data Bioinformatics 2020 36 i389 i398 10.1093/bioinformatics/btaa462 32657401 PMC7355236 · DOI · Paper page
  39. [48]Li Y Dou Y Da Veiga LF Geffen Y Calinawan AP Aguet F Akiyama Y Anand S Birger C Cao S Proteogenomic data and resources for pan-cancer analysis Cancer Cell 2023 41 1397 1406 10.1016/j.ccell.2023.06.009 37582339 PMC10506762 · DOI
  40. [49]Schaafsma E Fugle CM Wang X Cheng C Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy Br J Cancer 2021 125 422 432 10.1038/s41416-021-01400-2 33981015 PMC8329209 · DOI
  41. [50]Elazezy M Schwentesius S Stegat L Wikman H Werner S Mansour WY Failla AV Peine S Müller V Thiery JP Emerging insights into keratin 16 expression during metastatic progression of breast cancer Cancers 2021 13 3869 10.3390/cancers13153869 34359774 PMC8345379 · DOI
  42. [51]Lin YH Lim SN Chen CY Chi HC Yeh CT Lin WR Functional role of mitochondrial DNA in cancer progression Int J Mol Sci 2022 23 1659 10.3390/ijms23031659 35163579 PMC8915179 · DOI
  43. [52]Yuan X Yi M Dong B Chu Q Wu K Prognostic significance of KRT19 in lung squamous cancer J Cancer 2021 12 1240 10.7150/jca.51179 33442422 PMC7797641 · DOI
  44. [53]Yang B Zhang W Zhang M Wang X Peng S Zhang R KRT6A promotes EMT and cancer stem cell transformation in lung adenocarcinoma Technol Cancer Res Treat 2020 19 1533033820921248 10.1177/1533033820921248 32329414 PMC7225834 · DOI
  45. [54]Duan Y Zhang X Ying H Xu J Yang H Sun K He L Li M Ji Y Liang T Bai X Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix Oncogene 2023 42 2061 2073 10.1038/s41388-023-02711-9 37156839 PMC10275759 · DOI
  46. [55]Pan K Huang X Jia X SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu Oncol Lett 2021 21 485 10.3892/ol.2021.12746 33968201 PMC8100956 · DOI
  47. [56]Fan F Zhang H Dai Z Zhang Y Xia Z Cao H Yang K Hu S Guo Y Ding F A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing Cell Oncol (Dordr) 2021 44 917 935 10.1007/s13402-021-00612-1 34142341 PMC12980789 · DOI
  48. [57]Kuai X Lv J Zhang J Xu M Ji J Serpin family A member 1 is prognostic and involved in immunological regulation in human cancers Int J Mol Sci 2023 24 11566 10.3390/ijms241411566 37511325 PMC10380780 · DOI
  49. [58]Jing X Liang H Hao C Yang X Cui X Overexpression of MUC1 predicts poor prognosis in patients with breast cancer Oncol Rep 2019 41 801 810 30483806 PMC6313072
  50. [59]McGranahan N Swanton C Clonal heterogeneity and tumor evolution: past, present, and the future Cell 2017 168 613 628 10.1016/j.cell.2017.01.018 28187284 · DOI · Paper page
  51. [60]Nguyen ND Jin T Wang D Varmole: a biologically drop-connect deep neural network model for prioritizing disease risk variants and genes Bioinformatics 2021 37 1772 1775 10.1093/bioinformatics/btaa866 33031552 PMC8289382 · DOI
  52. [61]Janizek JD Spiro A Celik S Blue BW Russell JC Lee TI Kaeberlin M Lee SI PAUSE: principled feature attribution for unsupervised gene expression analysis Genome Biol 2023 24 81 10.1186/s13059-023-02901-4 37076856 PMC10114348 · DOI
  53. [63]Chen T, Kornblith S, Norouzi M, Hinton G. A simple framework for contrastive learning of visual representations. In International conference on machine learning. PMLR, Virtual Event; 2020; p. 1597–1607.
  54. [64]Chun S Oh SJ De Rezende RS Kalantidis Y Larlus D Probabilistic embeddings for cross-modal retrieval Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition 2021 8415 8424
  55. [65]You K, Liu Y, Wang J, Long M. Logme: Practical assessment of pre-trained models for transfer learning. In international conference on machine learning. PMLR, Virtual Event; 2021. p. 12133–12143.
  56. [66]Fisher LD Lin DY Time-dependent covariates in the Cox proportional-hazards regression model Annu Rev Public Health 1999 20 145 157 10.1146/annurev.publhealth.20.1.145 10352854 · DOI
  57. [67]Zhu X Yao J Zhu F Huang J Making survival prediction from whole slide histopathological images Proceedings of the IEEE conference on computer vision and pattern recognition 2017 7234 7242
  58. [68]Zadeh SG Schmid M Bias in cross-entropy-based training of deep survival networks IEEE Trans Pattern Anal Mach Intell 2020 43 3126 3137 10.1109/TPAMI.2020.2979450 32149626 · DOI
  59. [70]Sasieni P Maximum weighted partial likelihood estimators for the Cox model J Am Stat Assoc 1993 88 144 152 10.1080/01621459.1993.10594304 · DOI
  60. [75]Gao, H. Korn, JM. Ferretti, S. Monahan, JE. Wang, Y. Singh, M. Zhang, C. Schnell, C. Yang, G. Zhang, Y. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Genomic profiling of PDXs and raw response and curve metrics of PCTs. Springer. 2015. https://static-content.springer.com/esm/art%3A10.1038%2Fnm.3954/MediaObjects/41591_2015_BFnm3954_MOESM10_ESM.xlsx. 26479923
  61. [77]Wang, F. Zhuang, Z. Liu, J. TMO-Net: an explainable pretrained multi-omics model for multi-task learning in oncology. Github; 2024. https://github.com/FengAoWang/TMO-Net. PMC11157742 38845006
  62. [78]Wang, F. Zhuang, Z. Liu, J. TMO-Net: an explainable pretrained multi-omics model for multi-task learning in oncology. Zenodo; 2024. 10.5281/zenodo.11258239. PMC11157742 38845006 · DOI

Cited by

Sorted by citations

Authors
Wang, F.-A., Zhuang, Z., Gao, F., He, R., Zhang, S., Wang, L., Liu, J., & Li, Y.
Affiliations
  • University of Chinese Academy of Sciences (CN)
  • Xiamen University (CN)
  • Sun Yat-sen University (CN)
  • Shanghai Artificial Intelligence Laboratory (CN)
  • Guangzhou Laboratory (CN)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Wang, Liansheng
  • Liu, Junwei
  • Li, Yixue
Venue
Genome Biology
Published
2024-06-06
Volume
25
Issue
1
Pages
149-149
ISSN
  • 1465-6906 (ISSN-L)
  • 1474-760X
OpenAlex
W4399390205
Cited by
51
References
10
Citations by year
2026: 15 · 2025: 32 · 2024: 4
FWCI
7.08
Type
journal article
Language
en
Open access
Locations
  • Genome biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • CAS Research Fund (XDB38050200)
  • Self-supporting Program of Guangzhou Laboratory (SRPG22001, SRPG22007)
  • Key Technologies Research and Development Program (2022YFF1202101)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Keywords
multi-omics integration, pan-cancer, multi-task learning, pre-training, representation learning, explainable learning, interpretable learning, clinical outcomes, foundation models, oncology
MeSH terms
Machine Learning, Multiomics, Humans, Medical Oncology, Neoplasms, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review